ValoreQ4, 24TTMSpese di vendita, generali e amministrative——Ricerca e sviluppo——Reddito operativo——Proventi non operativi, Totale——Oneri finanziari, al netto degli interessi capitalizzati——Proventi non operativi, esclusi gli oneri finanziari——Entrate/uscite straordinarie——Utile al lordo delle imposte——Quota di utile——Imposte——Interessi di minoranza——Altri proventi/oneri al netto delle imposte——Utile netto al lordo delle attività cessate——Attività cessate——Utile netto——Regolazione della diluizione——Dividendi privilegiati——Utile netto diluito attribuibile agli azionisti ordinari——Utile base per azione (EPS base)——Utile diluito per azione (EPS diluito)——Numero medio di azioni ordinarie in circolazione——Azioni diluite in circolazione——EBITDA——EBIT——Costo del fatturato——Altri costi del venduto——Ammortamento e svalutazione (liquidità)——
Aurora Cannabis Inc
Aurora Cannabis Inc. is a Canadian licensed cannabis producer, headquartered in Edmonton. It trades on the Toronto Stock Exchange and Nasdaq as ACB. As of September 2018, Aurora Cannabis had eight licensed production facilities, five sales licences, and operations in 25 countries. It had a funded capacity of over 625,000 kilograms of cannabis production per annum with the bulk of capacity based in Canada and a growing presence in international markets, particularly Denmark and Latin America. The company began trading on the NYSE on October 23, 2018, using the ticker ACB.
After significant expansion in 2018, the company reduced expenses in the second half of 2019 when the Canadian recreational cannabis market had low sales due to excessive inventory and uncompetitive pricing with the black market. In February 2020, cofounder and chief executive, Terry Booth, resigned, being replaced by Executive Chairman Michael Singer as interim CEO.